Vericel (VCEL) Accumulated Depreciation & Amortization (2011 - 2026)
Vericel recorded quarterly Accumulated Depreciation & Amortization of $34.7 million in Q1 2026, up 9.86% quarter-over-quarter from $31.6 million in Q4 2025, and up 49.02% year-over-year from $23.3 million in Q1 2025.
Vericel's Accumulated Depreciation & Amortization history runs 16 years deep, the most recent figure standing at $34.7 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization rose 49.02% year-over-year to $34.7 million; the TTM figure through Mar 2026 stood at $34.7 million (up 49.02% YoY), while the FY2025 annual figure was $31.6 million, up 17.29% from the prior year.
- Accumulated Depreciation & Amortization came in at $34.7 million for Q1 2026 at Vericel, up from $31.6 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $34.7 million in Q1 2026 to a low of $900000.0 in Q1 2022.
- A 5-year average of $19.7 million and a median of $23.3 million in 2025 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization decreased 26.96% in 2022 and surged 2033.56% in 2023, its largest moves.
- Vericel's Accumulated Depreciation & Amortization stood at $4.0 million in 2022, then jumped by 455.15% to $22.2 million in 2023, then gained by 21.13% to $26.9 million in 2024, then increased by 17.29% to $31.6 million in 2025, then advanced by 9.86% to $34.7 million in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $34.7 million, $31.6 million, and $28.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.66 Mn |
| Mar 31, 2026 | 34.66 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Sep 30, 2025 | 28.72 Mn |
| Sep 30, 2025 | 28.72 Mn |
| Jun 30, 2025 | 25.93 Mn |
| Jun 30, 2025 | 25.93 Mn |
| Mar 31, 2025 | 23.26 Mn |
| Mar 31, 2025 | 23.26 Mn |
| Dec 31, 2024 | 26.90 Mn |
| Dec 31, 2024 | 26.90 Mn |
| Sep 30, 2024 | 25.58 Mn |
| Sep 30, 2024 | 25.58 Mn |
| Jun 30, 2024 | 24.60 Mn |
| Jun 30, 2024 | 24.60 Mn |
| Mar 31, 2024 | 23.43 Mn |
| Mar 31, 2024 | 23.43 Mn |
| Dec 31, 2023 | 22.21 Mn |
| Dec 31, 2023 | 22.21 Mn |
| Sep 30, 2023 | 21.21 Mn |
| Sep 30, 2023 | 21.21 Mn |
| Jun 30, 2023 | 20.22 Mn |
| Jun 30, 2023 | 20.22 Mn |
| Mar 31, 2023 | 19.20 Mn |
| Mar 31, 2023 | 19.20 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 900,000.00 |
| Mar 31, 2022 | 900,000.00 |
| Dec 31, 2021 | 3.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 700,000.00 |
| Sep 30, 2021 | 700,000.00 |
| Jun 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 1.51 Mn |
| Mar 31, 2021 | 811,000.00 |
| Mar 31, 2021 | 811,000.00 |
| Dec 31, 2020 | 2.40 Mn |
| Dec 31, 2020 | 2.40 Mn |
| Sep 30, 2020 | 10.71 Mn |
| Sep 30, 2020 | 10.71 Mn |
| Jun 30, 2020 | 10.14 Mn |
| Jun 30, 2020 | 10.14 Mn |
| Mar 31, 2020 | 9.63 Mn |
| Mar 31, 2020 | 9.63 Mn |
| Dec 31, 2019 | 1.70 Mn |
| Dec 31, 2019 | 1.70 Mn |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Mar 31, 2019 | 300,000.00 |
| Mar 31, 2019 | 300,000.00 |
| Dec 31, 2018 | 1.43 Mn |
| Dec 31, 2018 | 1.43 Mn |
| Sep 30, 2018 | 300,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Mar 31, 2018 | 427,000.00 |
| Mar 31, 2018 | 427,000.00 |
| Dec 31, 2017 | 1.61 Mn |
| Dec 31, 2017 | 1.61 Mn |
| Sep 30, 2017 | 1.20 Mn |
| Sep 30, 2017 | 1.20 Mn |
| Jun 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 400,000.00 |
| Mar 31, 2017 | 409,000.00 |
| Mar 31, 2017 | 409,000.00 |
| Dec 31, 2016 | 1.89 Mn |
| Dec 31, 2016 | 1.89 Mn |
| Sep 30, 2016 | 1.39 Mn |
| Sep 30, 2016 | 1.39 Mn |
| Jun 30, 2016 | 923,000.00 |
| Jun 30, 2016 | 923,000.00 |
| Mar 31, 2016 | 445,000.00 |
| Mar 31, 2016 | 445,000.00 |
| Dec 31, 2015 | 1.59 Mn |
| Dec 31, 2015 | 1.59 Mn |
| Sep 30, 2015 | 400,000.00 |
| Sep 30, 2015 | 400,000.00 |
| Jun 30, 2015 | 200,000.00 |
| Jun 30, 2015 | 200,000.00 |
| Mar 31, 2015 | 328,000.00 |
| Mar 31, 2015 | 328,000.00 |
| Dec 31, 2014 | 752,000.00 |
| Dec 31, 2014 | 752,000.00 |
| Sep 30, 2014 | 496,000.00 |
| Sep 30, 2014 | 496,000.00 |
| Jun 30, 2014 | 246,000.00 |
| Jun 30, 2014 | 246,000.00 |
| Mar 31, 2014 | 97,000.00 |
| Mar 31, 2014 | 97,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Dec 31, 2012 | 3.60 Mn |
| Dec 31, 2012 | 3.60 Mn |
| Dec 31, 2011 | 4.14 Mn |
| Dec 31, 2011 | 4.14 Mn |